SOLV — Solventum Corp
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1964738 ·
Last close
$86.06
Market Cap
$14.63B
52W High
$94.16
52W Low
$62.38
ADV30
1,208,690
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 2,209,000,000 | 1,286,000,000 | 181,000,000 | 92,000,000 | 14,243,000,000 | 403,000,000 | 9,444,000,000 |
| Mar 2026 | 2,006,000,000 | 1,095,000,000 | 79,000,000 | 13,000,000 | 14,097,000,000 | 561,000,000 | 9,127,000,000 |
| Dec 2025 | 1,998,000,000 | 1,027,000,000 | 93,000,000 | 63,000,000 | 14,294,000,000 | 878,000,000 | 9,244,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$207,000,000
Investing CF
$2,857,000,000
Financing CF
$-3,159,000,000
CapEx
$-327,000,000
Dividends Paid
—
Buybacks
$-355,000,000
EPS Diluted TTM
$0.89
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$1,902,000,000
Inventory
$1,040,000,000
Receivables
$1,432,000,000
ST Investments
—
EBIT TTM
$1,962,000,000
Pretax Income TTM
$1,696,000,000
Interest Exp TTM
$266,000,000
Analysts
13
Yahoo Snapshot (yfinance, live)
Total Revenue
$8,161,999,872
EBITDA
$1,036,000,000
Free Cash Flow
$201,750,000
Enterprise Value
$20,183,703,552
Total Cash
$451,000,000
Total Debt
$5,273,999,872
Shares Out
169,956,897
Trailing EPS
$0.89
Book Value
$28.27
ROE
3.2%
ROA
2.3%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 8,325,000,000 | 632,000,000 | 1,556,000,000 | 14,294,000,000 | 9,244,000,000 | 5,050,000,000 | 369,000,000 |
| Dec 2024 | 8,254,000,000 | 1,036,000,000 | 479,000,000 | 14,457,000,000 | 11,498,000,000 | 2,959,000,000 | 1,185,000,000 |
| Dec 2023 | 8,197,000,000 | 1,636,000,000 | 1,346,000,000 | 13,943,000,000 | 2,277,000,000 | 11,666,000,000 | 1,915,000,000 |
| Dec 2022 | 8,130,000,000 | 1,693,000,000 | 1,343,000,000 | 13,594,000,000 | 1,852,000,000 | 11,742,000,000 | 1,679,000,000 |
TTM Snapshot
Revenues TTM
$8,310,000,000
NetIncome TTM
$1,434,000,000
OpCashFlow TTM
—
Assets (Latest)
$14,243,000,000
Forward EPS
$7.41
Max Pain — expiry 2027-01-15
max pain strike: $80.00 · spot: $86.48 · call oi: 3,597 · put oi: 256
Expected Move to 2027-01-15:
±$8.43
(9.75%) —
implied range
$78.05 –
$94.91
· ATM straddle on $85.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GKOS | GLAUKOS Corp | $14.40B | $243.25 | — |
| BAX | BAXTER INTERNATIONAL INC | $13.33B | $25.76 | — |
| SNNUF | SMITH & NEPHEW PLC | $12.93B | $15.45 | — |
| SNN | SMITH & NEPHEW PLC | $12.77B | $30.51 | — |
| PEN | Penumbra Inc | $12.58B | $319.11 | — |
News headlines (Yahoo Finance, 1h cache)
Is Wall Street Bullish or Bearish on Solventum Stock?
2026-11-18 08:12 · Yahoo
SOLV Q3 2026 deep dive: ERP transition, separation milestones, and margin focus define quarter
2026-11-10 12:29 · Yahoo
Solventum (SOLV) stock trades up, here is why
2026-11-10 07:17 · Yahoo
Solventum Q3 Earnings Call Highlights
2026-11-08 23:14 · Yahoo
What Is Solventum (SOLV) Signaling With Its 90% Separation And HIS Split Plan?
2026-11-07 02:17 · Yahoo
SOLV Q3 Earnings Beat Estimates Despite ERP-Related Revenues Decline
2026-11-06 15:02 · Yahoo
Solventum Corp (SOLV) Q3 2026 Earnings Call Highlights: Separation Nears Completion as EPS ...
2026-11-06 11:16 · Yahoo
Solventum (SOLV) Raises Guidance After Q3 Beat, Is The Stock Still Undervalued?
2026-11-06 09:17 · Yahoo
Solventum (SOLV) Q3 2026 Earnings Call Transcript
2026-11-06 07:31 · Yahoo
Solventum (NYSE:SOLV) beats Q3 2026 sales expectations
2026-11-05 22:47 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.